Subscribe free

Sarcoma & rare tumors ·

High preoperative HbA1c levels correlate with poorer outcomes in GEP-NET patients

Higher preoperative glycosylated hemoglobin A1C (HbA1c) levels significantly affect long-term outcomes in patients undergoing resection for nonfunctional gastroenteropancreatic neuroendocrine tumors (GEP-NETs). A study involving 190 patients revealed that those with HbA1c ≥ 6.5% experienced increased complications and markedly reduced median overall survival (89.8 months vs. not reached for low HbA1c). This association highlights the need for enhanced monitoring and management of elevated HbA1c post-surgery.

Journal Article by Li MX, Lopez-Aguiar AG (…) Pawlik TM et 8 al. in J Surg Oncol

© 2024 The Author(s). Journal of Surgical Oncology published by Wiley Periodicals LLC.

read the whole article in J Surg Oncol

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Sarcoma & rare tumors.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Sarcoma & rare tumors

The latest stitches

Ann Surg Oncol26 Oct 2026

SSTR PET finds more distant disease in GEP-NETs

In this 24-year surgical cohort, SSTR PET identified bone and retroperitoneal nodal metastases more often than Octreoscan—findings that may matter for operative planning.

Ann Surg Oncol11 May 2026

Mapping Surgical Evidence for GEP-NETs

Surgical management of gastro-entero-pancreatic neuroendocrine tumors is inconsistent, highlighting the need for clearer guidelines.

All papers in Sarcoma & rare tumors →